Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) has received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation®. The approval means that RayStation® can now be sold on the Chinese market. Since November 2011, RaySearch is represented on the Chinese market by the distributor Kang Li Da Trading Corporation, based in Beijing. Kang Li Da has so far been active in pre-marketing activities and in the regulatory process to get CFDA approval. Now when market approval has been secured Kang Li Da will be fully responsible for marketing, sales and service for RayStation® on the entire Chinese market.
Help employers find you! Check out all the jobs and post your resume.
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) has received regulatory market approval by the Chinese regulatory agency CFDA for RaySearch’s treatment planning system RayStation®. The approval means that RayStation® can now be sold on the Chinese market. Since November 2011, RaySearch is represented on the Chinese market by the distributor Kang Li Da Trading Corporation, based in Beijing. Kang Li Da has so far been active in pre-marketing activities and in the regulatory process to get CFDA approval. Now when market approval has been secured Kang Li Da will be fully responsible for marketing, sales and service for RayStation® on the entire Chinese market.
Help employers find you! Check out all the jobs and post your resume.
